Gonadotropin Releasing Hormone agonist (GnRHa) during chemotherapy and post-cancer childbirths – a Nationwide population-based cohort study of 24,922 women diagnosed with cancer in SwedenResearch in context

Summary: Background: Worldwide, an increasing number of women with cancer are receiving Gonadotropin Releasing Hormone agonist (GnRHa) co-treatment during chemotherapy aiming at ovarian protection. There is divergence among guidelines, and some have recommended GnRHa co-treatment for women with bre...

Full description

Bibliographic Details
Main Authors: Kenny A. Rodriguez-Wallberg, Helle Kieler, Theodoros Foukakis, Jiong Li, Mika Gissler, Anna Sara Oberg, Jonas Bergh, Frida E. Lundberg
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023005126